(MedPage Today) — Biologics targeting interleukin (IL)-12, IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a Canadian cohort study showed.
For more than 11,000 older adults started…
Source link : https://www.medpagetoday.com/dermatology/psoriasis/114768
Author :
Publish date : 2025-03-21 16:12:00
Copyright for syndicated content belongs to the linked Source.